-
Lebanon wants Israel security deal, Hezbollah disarmament without confrontation: president to AFP
-
English village votes to 'secede' from UK over asylum centre plan
-
BASIS.pro Expands On-Chain Infrastructure with XDC Network Partnership and Zypher DAO as Auto Earn Goes Live
-
Wildfires push endangered Sumatran elephants to brink: Indonesian NGO
-
Samson relishing battle with teen star Sooryavanshi for India spot
-
Stocks head higher as traders prepare for Fed decision
-
Pickle-flavoured tart? AI inspires Japan's convenience stores
-
English village votes to 'secede' from UK over asylum centre
-
Macau holds first closed-door national security trial
-
Hong Kong unveils plan to align economy with China's goals
-
Bank of Japan set to raise rates under pressure from inflation, US
-
Brazilian voters the latest to eye Bukele security model with envy
-
Zverev, Shelton back on court for Davis Cup qualifiers
-
EU chief hosts Canada's Carney in push to 'deepen' alliance
-
Peace is a 'dangerous' word in Russian city heading to polls
-
EU chief to unveil social media, gaming curbs for under-15s
-
Meta chief pushes back on AI slowdown calls
-
Saudi says Houthis target Mecca, warn of 'red line'
-
'Resident Evil' film brings video game's ethos to the big screen
-
Asian stocks stutter as traders prepare for Fed decision
-
Court orders N. Korea pay Seoul $32.5 mn for blowing up office
-
US touts its power, avoids Iran war at G20 Energy meeting
-
US military buildup in Palau stirs war fears
-
Dead animals, barren fields, and hunger - El Nino chokes Central America
-
US Fed to deliver rate decision with markets betting on hike
-
In hydropowered Bhutan, solar starts to rise
-
Saudi, Egypt demand open Red Sea as Riyadh vows response to Houthi attacks
-
iQ Biosciences and Bioz Celebrate a Longstanding Partnership Advancing Cellular Product Discovery
-
VX Logistics Transforms Fresh Fruit and Vegetables Industry Through Application of AI and World-first Robot
-
FireFox Gold Announces Discovery of the Lammas Zone, Intersecting 21.0m at 4.13 g/t Gold More Than 650m From Previous Drilling at the Mustajärvi Project in Lapland, Finland
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - September 16
-
Great Western Mining Corporation Plc Announces Excellent Tungsten Recovery Rate from Bulk Sample
-
Tocvan Expands Near-Surface Gold at El Mezquite: 47.7 m of 0.8 g/t Au Including 2.8 m of 8.4 g/t Au and 54 g/t Ag
-
8 Steps to Pivot Your Career After Job Loss
-
Physical Gold IRA Investing Guide Released by Experts (2026 Update)
-
Brazil's Supreme Court clashes over handling of probe involving judge
-
Capitals say hockey star Ovechkin 'was asked' to film Putin ad
-
Trump threatens to keep Kennedy Center shut if his name not added
-
Spurs in 'tough moment' after League Cup exit as De Zerbi says sorry
-
i-payout Expands U.S. Money Transmitter Licensing Footprint and Advances European EMI Strategy
-
Arteta salutes 'unbelievable' Dowman after Arsenal's teen star sinks Ipswich
-
Artists exit Sheeran tour in solidarity with Macklemore pro-Palestinian comments
-
Empty seats as schools reopen in Venezuela's quake-hit Guaira
-
Espi saves Real Madrid with late winner at Elche
-
Messi set for Argentina farewell in Benin friendly
-
Liverpool pile on misery for Spurs in League Cup, Dowman dazzles for Arsenal
-
Ton-up Brook leads from the front as England hammer Sri Lanka in 1st T20
-
Trump blasts Supreme Court justices over 'horrible' mail vote ruling
-
AI giants pursue self-regulation as safety fears mount
-
Maduro ally pleads guilty to US money laundering charges
Vibrating pill, ingestible sensor: mini robots tackle gut disorders
A pill that vibrates to relieve constipation, a sensor that can be tracked in the gut -- medical researchers are turning to tiny robots to treat or diagnose gastrointestinal disorders.
"This is a very booming field," said Saransh Sharma, a doctoral student at the California Institute of Technology (Caltech) involved in the development of the ingestible diagnostic sensor.
"You have medical robots that are so small you can just send them inside a person using the oral passage and they can do a lot of sensing and actuation inside the gut," Sharma told AFP.
About 16 of every 100 adults in the United States suffer from symptoms of constipation, according to the US health authorities, and the number doubles for Americans over the age of 60.
Researchers at the Massachusetts Institute of Technology (MIT) and Caltech have developed an ingestible sensor that can be monitored as it travels through the digestive tract.
The device, 20 millimeters in length and eight mm in diameter, could help physicians diagnose gastrointestinal motility disorders that prevent food from moving normally through the digestive tract.
The capsule's location reveals where a slowdown is taking place.
"That gives the doctor a lot of the essential information to do a better job in the curing and the diagnosis and the treatment plan," Sharma said.
The sensor could also provide an alternative to invasive procedures such as endoscopy or other diagnostic techniques such as nuclear imaging, X-rays or catheters.
It has been tested on pigs and the team behind the research hopes to eventually obtain the approval of the US Food and Drug Administration for human clinical trials.
"If we can demonstrate a device inside large animals like pigs up to a very high confidence, we can say that it will scale very well in human anatomy as well," Sharma said.
The authors published the results of their research on Monday in the journal Nature Electronics.
They said the sensor works by detecting a magnetic field produced by an electromagnetic coil located outside of the body.
The strength of the magnetic field varies with distance from the coil and the sensor's position within the digestive tract can be calculated to within millimeters based on measurement of the magnetic field.
- Vibrating capsule -
While the ingestible sensor is still in the development phase, an Israeli company called Vibrant Gastro recently began marketing a vibrating capsule in the United States designed to relieve chronic constipation.
The drug-free Vibrant capsule is intended for constipation sufferers who have not received bowel relief after a month of laxative treatments. It has been FDA-approved.
In a Phase 3 clinical trial of 300 people, participants who took Vibrant had bowel movements significantly more frequently than those who took a placebo.
The Vibrant capsule produces gentle vibrations to stimulate the colon and increases the number and frequency of bowel movements, according to the manufacturer.
Y.Kobayashi--AMWN